Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT01022931
NCT01022931CompletedNot Applicable

Evaluation of a New Virus(Influenza A H1N1/09) in Children: Epidemiology, Clinical Presentation and Outcome, and Response to Treatment

University Hospital, Geneva1 site in 1 country200 target enrollmentStarted: October 2009Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
200
Locations
1
Primary Endpoint
ABCB1 polymorphisms
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

This study aims to identify clinical symptoms and outcomes, as well as response to anti-viral treatment in children living in Geneva, with influenza A/ H1N1 infection during the current pandemic.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
— to 16 Years (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •suspicion of H1N1 infection

Exclusion Criteria

  • •Not available for a 30 days follow-up

Outcomes

Primary Outcomes

ABCB1 polymorphisms

Time Frame: 6 months

ABCB1 gene polymorphisms and neuropsychiatric adverse events in oseltamivir-treated children during influenza H1N1/09 pandemia

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Klara M. Pósfay Barbe

Head of Pediatric Infectious Diseases

University Hospital, Geneva

Study Sites (1)

Loading locations...

Similar Trials

Unknown
Phase 2
Basic and Clinical Research on Applying Blood Fix to Treat Critical H1N1 PatientsVirus DiseasesRespiratory Tract DiseasesRespiratory Tract InfectionsOrthomyxoviridae InfectionsInfluenza
NCT01055990Shanghai Public Health Clinical Center7
Recruiting
Not Applicable
Influenza trial.RA, reuma, Rheumatoid Arthritis
NL-OMON21325Academisch Medisch Centrum, div Immunology and Rheumatology10
Completed
Phase 4
Rapid Evaluation of Pandemic H1N1 Influenza Vaccine in Adults With HIVH1N1 InfluenzaHIV Infections
NCT01002040University of British Columbia150
Completed
Phase 4
Rapid Evaluation of Pandemic H1N1 Influenza Vaccine in Adults Receiving Seasonal Influenza VaccineH1N1 2009 InfluenzaInfluenza
NCT01000584David Scheifele309
Completed
Phase 4
Rapid Evaluation of Pandemic H1N1 Influenza Vaccine in Aboriginal Children and AdultsH1N1/2009 Influenza
NCT01001026David Scheifele156